256 related articles for article (PubMed ID: 15503150)
1. Midbrain-derived neural stem cells: from basic science to therapeutic approaches.
Storch A; Sabolek M; Milosevic J; Schwarz SC; Schwarz J
Cell Tissue Res; 2004 Oct; 318(1):15-22. PubMed ID: 15503150
[TBL] [Abstract][Full Text] [Related]
2. Restorative approaches in Parkinson's Disease: which cell type wins the race?
Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
[TBL] [Abstract][Full Text] [Related]
3. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
4. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
[TBL] [Abstract][Full Text] [Related]
5. In vitro assays for neural stem cell differentiation: induction of dopaminergic phenotype.
Daadi MM
Methods Mol Biol; 2008; 438():205-12. PubMed ID: 18369760
[TBL] [Abstract][Full Text] [Related]
6. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.
Andersson EK; Irvin DK; Ahlsiö J; Parmar M
Exp Cell Res; 2007 Apr; 313(6):1172-80. PubMed ID: 17291494
[TBL] [Abstract][Full Text] [Related]
7. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
Arias-Carrión O; Yuan TF
Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
[TBL] [Abstract][Full Text] [Related]
8. Developmental perspectives on human midbrain-derived neural stem cells.
Schwarz J
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S466-8. PubMed ID: 18267285
[TBL] [Abstract][Full Text] [Related]
9. Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats.
Kallur T; Darsalia V; Lindvall O; Kokaia Z
J Neurosci Res; 2006 Dec; 84(8):1630-44. PubMed ID: 17044030
[TBL] [Abstract][Full Text] [Related]
10. Developmental perspectives on human midbrain-derived neural stem cells.
Schwarz J; Schwarz SC; Storch A
Neurodegener Dis; 2006; 3(1-2):45-9. PubMed ID: 16909036
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.
Studer L; Tabar V; McKay RD
Nat Neurosci; 1998 Aug; 1(4):290-5. PubMed ID: 10195162
[TBL] [Abstract][Full Text] [Related]
12. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.
O'Keeffe FE; Scott SA; Tyers P; O'Keeffe GW; Dalley JW; Zufferey R; Caldwell MA
Brain; 2008 Mar; 131(Pt 3):630-41. PubMed ID: 18202103
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of an operationally-defined neural stem cell clone.
Parker MA; Anderson JK; Corliss DA; Abraria VE; Sidman RL; Park KI; Teng YD; Cotanche DA; Snyder EY
Exp Neurol; 2005 Aug; 194(2):320-32. PubMed ID: 15992799
[TBL] [Abstract][Full Text] [Related]
14. Survival and differentiation of transplanted neural stem cells in mice brain with MPTP-induced Parkinson disease.
Li XK; Guo AC; Zuo PP
Acta Pharmacol Sin; 2003 Dec; 24(12):1192-8. PubMed ID: 14653943
[TBL] [Abstract][Full Text] [Related]
15. Stem cell biology of the central nervous system.
Okano H
J Neurosci Res; 2002 Sep; 69(6):698-707. PubMed ID: 12205662
[TBL] [Abstract][Full Text] [Related]
16. Neural stem cells and neurodegeneration.
Storch A; Schwarz J
Curr Opin Investig Drugs; 2002 May; 3(5):774-81. PubMed ID: 12090552
[TBL] [Abstract][Full Text] [Related]
17. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
18. Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate.
Cesnulevicius K; Timmer M; Wesemann M; Thomas T; Barkhausen T; Grothe C
Stem Cells; 2006 Dec; 24(12):2776-91. PubMed ID: 16902196
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic properties and function after grafting of attached neural precursor cultures.
Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
